Tilray Launches Medical Cannabis Educational Platform
One of the largest cannabis operators in the world, Tilray Brands, Inc., has just released a new web platform, called WeCare-MedicalCannabis and purposed to educate on medical cannabis and its gains for human health. Billed as a comprehensive resource for medical cannabis education, the platform is available in four different languages, including English.
The WeCare-MedicalCannabis website contains information and resources for patients, caregivers, and healthcare professionals. The platform with its contents is designed to help people make informed decisions about the use of medicinal cannabis and how these products can support their health and well-being. The website provides information based on four European markets: the United Kingdom, Germany, France, and Portugal, and therefore is available in the languages of these four countries respectively.
"As global pioneers in medical cannabis, we are aware of the lack of access to science-based, medical cannabis education," said in a statement Sascha Mielcarek, Managing Director at Tilray Europe.
He added: "WeCare-MedicalCannabis was created to bridge that gap and help provide the needed resources to helping patients, caregivers, and healthcare professionals with the information they need to make informed decisions on medicinal cannabis."
The WeCare-MedicalCannabis web platform would be the latest project of Canadian giant Tilray. The company was founded in 2014 and four years later became the first medical cannabis exporter to the United States. Currently headquartered in New York City, it also has operations in Australia, New Zealand and Latin America, and growing facilities in Germany and Portugal.
Tilray has rapidly grown over the last five years. It has also just closed a transaction with HEXO, which was announced as a strategic alliance between the two companies, expected to deliver up to $80 million of shared cost savings within the next two years.
According to the latest insights from Canadian stocks, which is recovering from a mild setback caused by inflation, Tilray has climbed 13.5% on the Health Care Capped Index, just behind Canopy Growth with an 18.5% climb, and ahead of other operators such as Aurora Cannabis, Cronos Group, and Health Care.
Tilray CEO, Irwin Semon, has commented on Tilray's current performance in Canada in a recent keynote speech, saying, "Tilray will own Canada. It's the largest in Canada today, and it will get bigger."
S
Stephen Andrews
